KIT DE ENZIMOINMUNOANÁLISIS PARA LA DEERMINACIÓN CUANTITATIVA DE INFLIXIMAB (ANTI-TNFA) Y DE ANTICUERPOS ANTI- INFLIXIMAB EN SUERO O PLASMA HUMANO
Mexico·Clase I·III. Agentes de
diagnóstico·INOCHEM, S.A. DE C.V.·Registered May 16, 2024- Risk Class / Clase de Riesgo
- Clase I
- Product Type (Spanish)
- III. Agentes de diagnóstico
- Product Type (English)
- III. Agentes de diagnóstico
- Trade Name (Spanish)
- LISA-TRACKER INFLIXIMAB
- Trade Name (English)
- LISA-TRACKER INFLIXIMAB
- Analysis ID
- 1414R2024 SSA
- Registration Date
- May 16, 2024
- Name (Spanish)
- INOCHEM, S.A. DE C.V.
- Name (English)
- INOCHEM, S.A. DE C.V.
Access comprehensive regulatory information for KIT DE ENZIMOINMUNOANÁLISIS PARA LA DEERMINACIÓN CUANTITATIVA DE INFLIXIMAB (ANTI-TNFA) Y DE ANTICUERPOS ANTI- INFLIXIMAB EN SUERO O PLASMA HUMANO (KIT DE ENZIMOINMUNOANÁLISIS PARA LA DEERMINACIÓN CUANTITATIVA DE INFLIXIMAB (ANTI-TNFA) Y DE ANTICUERPOS ANTI- INFLIXIMAB EN SUERO O PLASMA HUMANO) in the Mexico medical device market through Pure Global AI's free database. This Clase I medical device is registered under COFEPRIS analysis ID 1414R2024 SSA and manufactured by INOCHEM, S.A. DE C.V.. The device was registered on May 16, 2024.
This page provides complete registration details including product type (III. Agentes de diagnóstico), manufacturer information, and regulatory compliance data from the official Mexico COFEPRIS medical device database. Pure Global AI offers free access to Mexico's complete medical device registry with bilingual Spanish/English support, helping global MedTech companies navigate COFEPRIS regulations efficiently.